HIPEC Methodology, Comparison of Techniques, and Drug Regimens: Is There a Need for Standardization?

作者: K. Van der Speeten , L. Lemoine

DOI: 10.1007/978-981-10-7053-2_4

关键词:

摘要: The introduction of cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy has greatly improved the prognosis patients with peritoneal carcinomatosis in both phase II III trials. A clear pharmacologic clinical rationale for this treatment strategy been demonstrated. Whereas highly standardized, reproducible, predictable, same cannot be said modalities. staggering variety application techniques regimens reported. Most these have based on extrapolation systemic data. An urgent need more standardization modalities is needed. aim manuscript to review rationale, variables, chemotherapy. At time, it seeks offer guidance current potential directions toward standardization.

参考文章(171)
David Jayne, Molecular Biology of Peritoneal Carcinomatosis Cancer treatment and research. ,vol. 134, pp. 21- 33 ,(2007) , 10.1007/978-0-387-48993-3_2
Michael F. Flessner, Intraperitoneal Drug Therapy: Physical and Biological Principles Cancer treatment and research. ,vol. 134, pp. 131- 152 ,(2007) , 10.1007/978-0-387-48993-3_8
Eelco Bree, Dimitris D. Tsiftsis, Experimental and Pharmacokinetic Studies in Intraperitoneal Chemotherapy: From Laboratory Bench to Bedside Recent results in cancer research. ,vol. 169, pp. 53- 73 ,(2007) , 10.1007/978-3-540-30760-0_5
Bettendorf U, Lymph flow mechanism of the subperitoneal diaphragmatic lymphatics. Lymphology. ,vol. 11, pp. 111- 116 ,(1978)
Steven E. Mutsaers, Sylwia Wilkosz, Structure and Function of Mesothelial Cells Cancer treatment and research. ,vol. 134, pp. 1- 19 ,(2007) , 10.1007/978-0-387-48993-3_1
Doroshow Jh, Grotzinger Kr, Locker Gy, Ozols Rf, Fisher Ri, Myers Ce, Young Rc, Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin. Cancer treatment reports. ,vol. 63, pp. 269- ,(1979)
Wim P. Ceelen, Sophie Morris, Paraskevas Paraskeva, Piet Pattyn, Surgical trauma, minimal residual disease and locoregional cancer recurrence. Cancer treatment and research. ,vol. 134, pp. 51- 69 ,(2007) , 10.1007/978-0-387-48993-3_4
Not Available Not Available, Not Available Not Available, Not Available Not Available, Not Available Not Available, Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Cancer Chemotherapy and Pharmacology. ,vol. 47, pp. 269- 276 ,(2001) , 10.1007/S002800000214
C. Pablo Carmignani, Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer and Metastasis Reviews. ,vol. 22, pp. 465- 472 ,(2003) , 10.1023/A:1023791229361
K Nagai, H Konishi, S Nogami, H Egusa, Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats. Die Pharmazie. ,vol. 69, pp. 125- 127 ,(2014)